DK162645C - Analogifremgangsmaade til fremstilling af 5-(2-imidazolylethoxy)-thiophen-2-carboxylsyrederivater - Google Patents

Analogifremgangsmaade til fremstilling af 5-(2-imidazolylethoxy)-thiophen-2-carboxylsyrederivater

Info

Publication number
DK162645C
DK162645C DK505583A DK505583A DK162645C DK 162645 C DK162645 C DK 162645C DK 505583 A DK505583 A DK 505583A DK 505583 A DK505583 A DK 505583A DK 162645 C DK162645 C DK 162645C
Authority
DK
Denmark
Prior art keywords
imidazolylethoxy
thiophene
preparing
carboxylic acid
acid derivatives
Prior art date
Application number
DK505583A
Other languages
Danish (da)
English (en)
Other versions
DK505583A (da
DK505583D0 (da
DK162645B (da
Inventor
Dieter Binder
Christian Noe
Original Assignee
Laevosan Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laevosan Gmbh & Co Kg filed Critical Laevosan Gmbh & Co Kg
Publication of DK505583D0 publication Critical patent/DK505583D0/da
Publication of DK505583A publication Critical patent/DK505583A/da
Publication of DK162645B publication Critical patent/DK162645B/da
Application granted granted Critical
Publication of DK162645C publication Critical patent/DK162645C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
DK505583A 1982-11-05 1983-11-04 Analogifremgangsmaade til fremstilling af 5-(2-imidazolylethoxy)-thiophen-2-carboxylsyrederivater DK162645C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT404182 1982-11-05
AT0404182A AT376436B (de) 1982-11-05 1982-11-05 Verfahren zur herstellung neuer thiophen-2carbons[urederivate und pharmazeutisch vertraeglicher saeure- oder basenadditionssalze davon

Publications (4)

Publication Number Publication Date
DK505583D0 DK505583D0 (da) 1983-11-04
DK505583A DK505583A (da) 1984-05-06
DK162645B DK162645B (da) 1991-11-25
DK162645C true DK162645C (da) 1992-04-13

Family

ID=3558851

Family Applications (1)

Application Number Title Priority Date Filing Date
DK505583A DK162645C (da) 1982-11-05 1983-11-04 Analogifremgangsmaade til fremstilling af 5-(2-imidazolylethoxy)-thiophen-2-carboxylsyrederivater

Country Status (9)

Country Link
US (1) US4590203A (fi)
EP (1) EP0109381B1 (fi)
JP (1) JPS59108780A (fi)
AT (1) AT376436B (fi)
CA (1) CA1209576A (fi)
DE (1) DE3364995D1 (fi)
DK (1) DK162645C (fi)
FI (1) FI75565C (fi)
PT (1) PT77613B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0284892B1 (de) * 1987-04-03 1990-10-31 Cl Pharma Aktiengesellschaft Neue 2-Thienyloxyessigsäurederivate, ein Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
AT395425B (de) * 1991-04-04 1992-12-28 Laevosan Gmbh & Co Kg Neue thiophen-2-carbonsaeurederivate und verfahren zu deren herstellung
US5608082A (en) * 1994-07-28 1997-03-04 Agouron Pharmaceuticals, Inc. Compounds useful as antiproliferative agents and GARFT inhibitors
US5527920A (en) * 1994-11-18 1996-06-18 Singh; Inder P. Economical manufacturing process for 1,2,3-triazoles
US6545163B1 (en) * 1995-10-02 2003-04-08 Napp Technologies Process to prepare 1-aryl-2-(1-imidazolyl) alkyl ethers and thioethers
JP5578809B2 (ja) * 2008-06-26 2014-08-27 石原産業株式会社 ３−メチル−２−チオフェンカルボン酸の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3186990A (en) * 1961-08-22 1965-06-01 Union Carbide Corp 2-thienylmethylmercaptoamidine hydrochlorides and cyclic derivatives thereof
SE339235B (fi) * 1965-06-01 1971-10-04 Haessle Ab
SU557755A3 (ru) * 1968-08-19 1977-05-05 Янссен Фармасьютика Н.В. (Фирма) Способ получени производных имидазола
US3658813A (en) * 1970-01-13 1972-04-25 Janssen Pharmaceutica Nv 1-(beta-aryl-beta-(r-oxy)-ethyl)-imidazoles
JPS5734275B2 (fi) * 1973-07-30 1982-07-22
US4087536A (en) * 1976-05-04 1978-05-02 The Dow Chemical Company Method for the use of thienylvinylimidazoles as anthelmintics
DK151884C (da) * 1979-03-07 1988-06-13 Pfizer Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf
DE2950064A1 (de) * 1979-12-13 1981-06-19 Basf Ag, 6700 Ludwigshafen Piperidinderivate von 3-hydroxythiophen-2-carbonsaeure und -estern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
DE2951601A1 (de) * 1979-12-21 1981-07-02 C.H. Boehringer Sohn, 6507 Ingelheim Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben

Also Published As

Publication number Publication date
EP0109381B1 (de) 1986-07-30
FI75565B (fi) 1988-03-31
DK505583A (da) 1984-05-06
CA1209576A (en) 1986-08-12
EP0109381A1 (de) 1984-05-23
ATA404182A (de) 1984-04-15
PT77613A (de) 1983-12-01
FI834023A (fi) 1984-05-06
FI75565C (fi) 1988-07-11
FI834023A0 (fi) 1983-11-02
DK505583D0 (da) 1983-11-04
PT77613B (de) 1986-03-19
DE3364995D1 (en) 1986-09-04
US4590203A (en) 1986-05-20
DK162645B (da) 1991-11-25
AT376436B (de) 1984-11-26
JPS59108780A (ja) 1984-06-23
JPH0210157B2 (fi) 1990-03-06

Similar Documents

Publication Publication Date Title
DK188683A (da) Fremgangsmaade til fremstilling af heterocycliske forbindelser
DK164593C (da) Analogifremgangsmaade til fremstilling af 1-phenyl-2-piperidinopropanolderivater
DK425579A (da) Fremgangsmaade til fremstilling af heterocycliske forbindelser
DK478980A (da) Fremgangsmaade til fremstilling af imidazol-5-eddikesyrederivater
DK280083D0 (da) Fremgangsmade til fremstilling af 2-(4-puridyl)-thiazolderivater
DK158788C (da) Analogifremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK151260C (da) Analogifremgangsmaade til fremstilling af spiro-thienohydantoinderivater.
DK357081A (da) Fremgangsmaade til fremstilling af heterocycliske forbindelser
DK149773C (da) Analogifremgangsmaade til fremstilling af 3-quinolincarboxylsyrederivater
DK155783A (da) Fremgangsmaade til fremstilling af phenoxyalkylcarboxylsyrederivater
DK145698C (da) Analogifremgangsmaade til fremstilling af 2-alkoxyadeninderivater
DK158669C (da) Fremgangsmaade til fremstilling af 6beta-halogensubstituerede penicillansyrederivater.
DK163580C (da) Analogifremgangsmaade til fremstilling af cyclohexancarboxylsyrederivater
DK103683D0 (da) Fremgangsmade til fremstilling af 2-keto-l-gulonsyre
DK103583D0 (da) Fremgangsmade til fremstilling af 2-keto-l-gulonsyre
DK147145C (da) Analogifremgangsmaade til fremstilling af chlorambucilderivater
DK388079A (da) R fremgangsmaade til fremstilling af heterocycliske forbindelse
DK153583D0 (da) Fremgangsmade til fremstilling af substituerede penemderivater
DK34781A (da) Fremgangsmaade til fremstilling af phenylalkansyrederivater
DK161310C (da) Analogifremgangsmaade til fremstilling af aminopropoxyphenylderivater
DK501781A (da) Fremgangsmaade til fremstilling af 2-oxoazetidin-derivater
DK162645C (da) Analogifremgangsmaade til fremstilling af 5-(2-imidazolylethoxy)-thiophen-2-carboxylsyrederivater
DK163000C (da) Analogifremgangsmaade til fremstilling af vinylthioacetamido-1-dethia-1-oxa-cephalosporinderivater
DK372081A (da) Fremgangsmaade til fremstilling af fluorerede pentendiaminderivater
DK152674C (da) Analogifremgangsmaade til fremstilling af 3-metyltiometyl-4-oxo-quinolonderivater

Legal Events

Date Code Title Description
PBP Patent lapsed